ACE and Stroke: Systemic inflammation is not only a predictor to worse outcome in stroke patients [2,3] but anaphylactoid reactions may occur in response to thrombolytic treatment in stroke patients taking an angiotensin-converting-enzyme inhibitor [38,39].